718P A phase II study of patients with advanced or metastatic renal cell carcinoma (mRCC) receiving pazopanib after previous checkpoint inhibitor treatment
| Autor: | Powles, T.B., Oudard, S., Grünwald, V., Calvo, E., Michaelson, M.D., Burotto, M., Melichar, B., Tyagi, R., Hilmi, F., Gaur, A., Hirschberg, Y., Heng, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S564-S564 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|